A new organization in Korea is hoping to influence lawmakers to legalize medical cannabis.
There’s been mixed findings on whether cannabis can be an antipsychotic. Now, new research out of Brazil finds that at least one cannabinoid—CBD for schizophrenia—could be an effective treatment.
The fentanyl execution holds significance as fentanyl is fueling the opioid crisis.
Oklahoma just legalized medical marijuana, but the state’s biggest universities have announced they won’t be allowing it on campus.
Our regulations don’t reflect what we know.
Support for cannabis reform varies drastically from city to city, but overall, support is on the rise.
New research challenges the munchies stereotype.
Legalization would bring in revenue and cut down on enforcement costs.
It could set the precedent for large companies in America to stop discriminating against employees who use marijuana after work.
Nabilone could be an alternative to current meds which cause a heightened risk of stroke and even death.
There is, however, a tipping point in pricing where consumers will go from a legal market purchase to the black market — but they much prefer the former.
Laboratory tests don’t lie, and in this case, the results are revealing contaminated or mislabeled cannabis.
Pregnant women are among those choosing to cannabis over nicotine.
Colombia’s climate and farming industry perfectly position it to dominate the global cannabis market.
They banned “wet cannabis,” but all cannabis must go through this phase before it can be consumed.
Researchers at the Washington University School of Medicine find evidence supporting decriminalization.
There’s an epidemic of brain injuries in football and hardly any options to treat them.
Remnants of cannabis prohibition linger in the insurance market.